Roche Receives CE Mark for Accu-Chek SugarView Smartphone App
The app will enable broader access to therapy-relevant information for non-insulin-dependent people with type 2 diabetes or prediabetes.
Read MorePosted by | Feb 7, 2020 | POC Instruments, Point-of-Care |
The app will enable broader access to therapy-relevant information for non-insulin-dependent people with type 2 diabetes or prediabetes.
Read MorePosted by | Jan 14, 2020 | Research |
Daughters of women with polycystic ovarian syndrome are five times more likely to be diagnosed with the syndrome as adults, and the generational transmission is driven by high androgen levels during pregnancy.
Read MorePosted by Steve Halasey | Nov 12, 2019 | Allergy & Autoimmune, Point-of-Care |
The company will use the funds to develop and market near-patient, 2- to 5-minute tests to detect and monitor biomarkers for inflammatory and autoimmune diseases and for metabolic syndromes.
Read MorePosted by Steve Halasey | Sep 11, 2019 | Blood Gas Analyzers, Controls, Culture Media, Software |
Labs reap the benefits of automated QC and interlaboratory peer-reporting systems.
Read MorePosted by Steve Halasey | Sep 3, 2019 | Point-of-Care, Research |
A study of point-of-care HbA1c testing confirms the benefits of using the Quo-Test analyzer for patients with sight-threatening diabetic retinopathy.
Read More